diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. aged 14-70 years old male and female; 2. All participants agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Diabetic patients with poor blood glucose control: HbA1c >9.5%; 2. Use of drugs that may affect the outcome measures of this study 1 months before enrollment, including pioglitazone, GLP-1 receptor agonist, DPP-4 inhibitor, insulin, and glycyrrhizic acid preparation, etc; 3. Accompanied by other diseases that affect glucose and lipid metabolism, such as hypothyroidism, hyperthyroidism, hypercortisolism, etc; 4. Accompanied by severe liver diseases caused by viral hepatitis, drugs, auto-immune hepatitis, hereditary liver disease, liver cirrhosis, liver cancer, etc; 5. Accompanied by biliary tract diseases, biliary obstructive disease, etc; 6. Accompanied by chronic kidney disease or severe renal impairment, defined as serum creatinine greater than 2.0mg/dL (176.8umol/L); 7. Life expectancy is no more than 5 years; 8. Pregnant or planning to become pregnant recently for female participant; 9. There is a chewing dysfunction or eating disorder; 10. Allergic to some food, or for alcohol or iodine using for skin disinfection; 11. Can't accept indwelling needles in the body; 12. Any situation that may affect the implementation or results of the study; 13. Subjects participated in other clinical trials in the past 4 weeks; 14. The researchers think they were unsuitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postprandial blood glucose; | — |
Secondary
| Measure | Time frame |
|---|---|
| glucose excursion;HbA1c; | — |
Countries
China
Contacts
Zhongshan Hospital, Fudan University